Cocrystal Pharma (COCP) Free Cash Flow (2010 - 2026)
Cocrystal Pharma (COCP) reported Free Cash Flow of -$2.3 million for Q1 2026, up 20.38% on a YoY basis from -$1.9 million in Q1 2025, and down 34.17% sequentially from -$1.7 million in Q4 2025.
Cocrystal Pharma (COCP) Free Cash Flow (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 16 years of Free Cash Flow data on file, last reported at -$2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 20.38% year-over-year to -$2.3 million; the trailing twelve-month figure through Mar 2026 stood at -$7.6 million (up 49.06% YoY), and the FY2025 full-year result was -$8.2 million, up 50.21% from the prior year.
- Free Cash Flow eased to -$2.3 million in Q1 2026, from -$1.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$1.4 million in Q3 2025 to a low of -$8.9 million in Q3 2022.
- A 5-year average of -$3.7 million and a median of -$3.4 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow slumped 117.83% in 2022 and soared 73.41% in 2025, its largest moves.
- Tracing COCP's Free Cash Flow over 5 years: stood at -$4.9 million in 2022, then soared by 30.99% to -$3.4 million in 2023, then rose by 6.65% to -$3.2 million in 2024, then soared by 44.81% to -$1.7 million in 2025, then tumbled by 34.17% to -$2.3 million in 2026.
- Business Quant data shows COCP's Free Cash Flow at -$2.3 million in Q1 2026, -$1.7 million in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -354.95 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | -2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.34 Mn |
| Mar 31, 2026 | -2.34 Mn |
| Dec 31, 2025 | -1.74 Mn |
| Dec 31, 2025 | -1.74 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | -2.16 Mn |
| Jun 30, 2025 | -2.16 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Mar 31, 2025 | -2.94 Mn |
| Dec 31, 2024 | -3.16 Mn |
| Dec 31, 2024 | -3.16 Mn |
| Sep 30, 2024 | -5.12 Mn |
| Sep 30, 2024 | -5.12 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Mar 31, 2024 | -4.51 Mn |
| Mar 31, 2024 | -4.51 Mn |
| Dec 31, 2023 | -3.39 Mn |
| Dec 31, 2023 | -3.39 Mn |